PRMT9 and hepatocellular carcinoma: In Hepatocellular carcinoma (HCC), PRMT9 increases its arginine methylation at R76 and R100 by targeting member 8 of the human heat shock homologous protein family A, accelerates the progression of HCC in vivo (Deng et al., 2023).